Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacogenomics in gastrointestinal disorders.

Stefan Schreiber1, Christine M Costello

  • 1From the 1st Department of Medicine, Christian-Albrechts-University, Kiel, Germany. s.schreiber@mucosa.de

The European Journal of Surgery. Supplement. : = Acta Chirurgica. Supplement
|September 8, 2005
PubMed
Summary

Genomic techniques are revolutionizing the study of intestinal disorders by identifying genetic variations that predict drug responses. This approach promises more precise treatments and deeper insights into chronic intestinal inflammation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elevated plasma CXCL12α is associated with a poorer prognosis in pulmonary arterial hypertension.

PloS one·2015
Same author

First multicenter study of modified release phosphatidylcholine "LT-02" in ulcerative colitis: a randomized, placebo-controlled trial in mesalazine-refractory courses.

The American journal of gastroenterology·2014
Same author

Commentary: vedolizumab: a new mechanism of action for the treatment of ulcerative colitis.

Gastroenterology & hepatology·2014
Same author

Mitochondrial DNA variants in obesity.

PloS one·2014
Same author

New tools and approaches for improved management of inflammatory bowel diseases.

Journal of Crohn's & colitis·2014
Same author

B Lymphocyte Stimulator (BLyS) is expressed in human adipocytes in vivo and is related to obesity but not to insulin resistance.

PloS one·2014

Area of Science:

  • Genomics and molecular biology
  • Gastroenterology
  • Pharmacogenetics

Background:

  • Genomic techniques provide novel avenues for investigating the causes and mechanisms of intestinal disorders.
  • Pharmacogenetic studies of gene variations can predict patient responses to specific medications, enabling targeted therapies.
  • Understanding gene expression globally may reveal new molecular pathways and therapeutic targets in gastrointestinal diseases.

Purpose of the Study:

  • To explore the application of genomic methods in understanding intestinal disorders.
  • To highlight the importance of pharmacogenetics in tailoring drug treatments for gastrointestinal conditions.
  • To emphasize the potential of global gene expression analysis in discovering new therapeutic strategies.

Main Methods:

Related Experiment Videos

  • Utilizing genomic techniques for disease investigation.
  • Conducting pharmacogenetic analyses of gene variations.
  • Employing global gene expression analysis.

    • Main Results:

    • Genomic approaches offer new insights into the aetiology and pathophysiology of intestinal disorders.
    • Pharmacogenetics can guide precise drug targeting for improved treatment outcomes.
    • Global gene expression analysis aids in identifying novel pathways and molecules.

    Conclusions:

    • Genomic methods are expected to significantly impact the treatment of gastrointestinal disorders.
    • These techniques will enhance our understanding of chronic intestinal inflammation.
    • Future research will leverage genomics for personalized medicine in gastroenterology.